Aarhus University Seal / Aarhus Universitets segl

Kirsten Bouchelouche

PET/Computed Tomography in Renal, Bladder, and Testicular Cancer

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Kirsten Bouchelouche
  • Peter L Choyke, Molecular Imaging Program, Building 10, Room B3B6B9F, Center for Cancer Research, National Cancer Institute (NCI), Bethesda, MD, USA.

Imaging plays an important role in the clinical management of cancer patients. Hybrid imaging with PET/computed tomography (CT) is having a broad impact in oncology, and in recent years PET/CT is beginning to have an impact in urooncology. In both bladder and renal cancers, there is a need to study the efficacy of other tracers than F-18 fluorodeoxyglucose (FDG), particularly tracers with limited renal excretion. Thus, new tracers are being introduced. This review focuses on the clinical role of FDG and other PET agents in renal, bladder, and testicular cancers.

OriginalsprogEngelsk
TidsskriftHand Clinics
Vol/bind10
Nummer3
Sider (fra-til)361-74
Antal sider14
ISSN0749-0712
DOI
StatusUdgivet - jul. 2015
Eksternt udgivetJa

Se relationer på Aarhus Universitet Citationsformater

ID: 103925727